Heart Failure Laboratory: Experience in a University Hospital View PDF

^*Dávolos Ignacio
Rehabilitacion Cardiovascular, Hospital De Clínicas “José De San Martín”, University Of Buenos Aires, Argentina

^*Corresponding Author:

Dávolos Ignacio
Rehabilitacion Cardiovascular, Hospital De Clínicas “José De San Martín”, University Of Buenos Aires, Argentina
Email:ignacio.davolos@hotmail.com

Published on: 2023-02-28

Abstract

Introduction: Most of the management of patients with heart failure (HF) is accomplished on an outpatient basis. Adherence to the recommended treatment standards and access to the health system determine their evolution. We describe our experience with patients with ambulatory HF in a University Hospital.
Material and Methods: Patients referred for inter-consultation to the HF Laboratory between the months of January 2021 and October 2022 were included. A structured intervention was carried out, which included face-to-face visits and follow-up by email and/or telephone and nutritional advice.
Results: 98 patients were included. The mean age was 64.05 years. The total mean LVEF was 36.26%. A significant association was observed between those over 60 years of age (n = 65; 66.33%) and dyslipidemia, arterial hypertension, oncological disease, and coronary disease, compared to younger individuals. The low LVEF was correlated with coronary and oncological disease. In them was observed greater use of beta-blockers, ARNI, iSGLT2, and acetylsalicylic acid. Male sex, decreased LVEF and age were predictors of a worse prognosis.
Conclusion: The use of pharmacological treatment in HF depends on multiple factors. Despite this, a distribution of the established therapy according to the guideline recommendation and national registries and hospitalizations of patients with HF was observed.

Keywords

Heart Failure; Treatment Adherence; Hospital Care

Introduction

Heart failure (IC) is one of the most incidence diseases, which generates the most hospitalizations and expenses to health systems in the Western world. It affects 2 - 3% of the general population but increases to more than 10% in those over 70 years. It is the common final route for the majority of heart diseases not properly treated [1,2]. Markedly affects the forecast and its associated morbidity and mortality is high [3]. Records of acute IC in different countries and contexts have been made [4,5]; In our country the most recent and with the largest number of patients is argen IC [6]. Recently, the results of the Office IC AR registry were published that specifically represents patients with chronic IC in outpatient monitor More relevant, therefore the appropriate daily behavior by the patient, the adherence to the recommended treatment standards and rapid access to the health system determine evolution. In the same way, the analysis of disparity in the degree of medical adhesion to guide indications in relation to pharmacological treatment is considered interesting [7-9]. Our country is no exception; in addition, the corporate records may not be truly considered representative of the Argentine reality since the geographical area effectively covered by the Argentine Society of Cardiology and the Argentine Federation of Cardiology is different from other rural areas [10]. On the other hand, the medical coverage systems vary significantly according to geographic zone or Medical Institution.
The primary objective of our registry was to describe a population of patients in follow-up by IC in a university hospital, in this case dependent on the University of Buenos Aires, including patient characteristics, use of diagnostic and therapeutic resources, adherence to the guides and prognosis of patients with ischemic-necrotic heart disease.